本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Forte BioSciences Inc

31.43
+0.15000.48%
盤後31.430.00000.00%17:36 EDT
成交量:20.18萬
成交額:618.16萬
市值:6.16億
市盈率:-6.67
高:31.57
開:30.91
低:29.76
收:31.28
52周最高:35.80
52周最低:4.90
股本:1,959.56萬
流通股本:1,651.21萬
量比:0.21
換手率:1.22%
股息:- -
股息率:- -
每股收益(TTM):-4.7137
每股收益(LYR):-12.1671
淨資產收益率:-122.28%
總資產收益率:-61.19%
市淨率:10.10
市盈率(LYR):-2.58

資料載入中...

2023/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/11

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/11

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/10

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/04

重要事件披露

Form 8-K - Current report
2023/08/03

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/02

重要事件披露

Form 8-K - Current report
2023/07/07

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/07/06

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/27

重要事件披露

Form 8-K - Current report
2023/05/26

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/01

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/04/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/31

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/31

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/31

重要事件披露

8-K - Current report
2023/03/29

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/21

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/09

重要事件披露

8-K - Current report